Participants will understand the ongoing need for oral on-demand treatments in hereditary
angioedema (HAE) despite the availability of effective prophylactic options, including
insights into patient preferences and treatment burdens associated with injectable therapies.
They will also gain up-to-date knowledge of the clinical development and trial data for
emerging oral therapies such as sebetralstat and deucrictibant
MODERATOR: Dr. Constance Katelaris
Western Sydney University & Campbelltown Hospital, Sydney, Australia
TALK 1: The Need for Oral On-Demand Therapies in HAE
Addressing Gaps Despite Effective Prophylaxis
Hon. Assoc. Prof. Dr. Hilary Longhurst | University of Auckland, New Zealand
(15 min)
TALK 2: Burden of Injectable On-Demand Treatments
Understanding Patient Preferences and Challenges
Dr. Marcin Stobiecki | University Hospital in Krakow, Poland
(15 min)
TALK 3: Emerging Oral Therapies in HAE
A Review of Clinical Trials with Sebetralstat and Deucrictibant
Asst. Prof. Dr. Anna Valerieva | Medical University of Sofia, Bulgaria
(15 min)
Discussion and Q&A
All Faculty
Moderated by Prof. Dr. Constance Katelaris
(10 min)
Closing Remarks
Prof. Dr. Constance Katelaris
(2 min)
